1. Home
  2. CVAC vs CNOB Comparison

CVAC vs CNOB Comparison

Compare CVAC & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • CNOB
  • Stock Information
  • Founded
  • CVAC 2000
  • CNOB 1982
  • Country
  • CVAC Germany
  • CNOB United States
  • Employees
  • CVAC N/A
  • CNOB N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • CNOB Major Banks
  • Sector
  • CVAC Health Care
  • CNOB Finance
  • Exchange
  • CVAC Nasdaq
  • CNOB Nasdaq
  • Market Cap
  • CVAC 812.1M
  • CNOB 871.0M
  • IPO Year
  • CVAC 2020
  • CNOB 1996
  • Fundamental
  • Price
  • CVAC $4.10
  • CNOB $22.98
  • Analyst Decision
  • CVAC Hold
  • CNOB Buy
  • Analyst Count
  • CVAC 3
  • CNOB 4
  • Target Price
  • CVAC $10.00
  • CNOB $27.75
  • AVG Volume (30 Days)
  • CVAC 1.2M
  • CNOB 218.3K
  • Earning Date
  • CVAC 11-12-2024
  • CNOB 01-30-2025
  • Dividend Yield
  • CVAC N/A
  • CNOB 3.13%
  • EPS Growth
  • CVAC N/A
  • CNOB N/A
  • EPS
  • CVAC N/A
  • CNOB 1.73
  • Revenue
  • CVAC $70,565,734.00
  • CNOB $248,641,000.00
  • Revenue This Year
  • CVAC $742.57
  • CNOB N/A
  • Revenue Next Year
  • CVAC N/A
  • CNOB $35.62
  • P/E Ratio
  • CVAC N/A
  • CNOB $13.29
  • Revenue Growth
  • CVAC 75.11
  • CNOB N/A
  • 52 Week Low
  • CVAC $2.22
  • CNOB $17.07
  • 52 Week High
  • CVAC $5.28
  • CNOB $29.31
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 62.06
  • CNOB 44.37
  • Support Level
  • CVAC $3.89
  • CNOB $22.54
  • Resistance Level
  • CVAC $4.32
  • CNOB $23.55
  • Average True Range (ATR)
  • CVAC 0.33
  • CNOB 0.71
  • MACD
  • CVAC 0.03
  • CNOB 0.16
  • Stochastic Oscillator
  • CVAC 54.27
  • CNOB 70.68

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a holding company. The company through its holding provides banking services including lending, depository, and related financial services to commercial, industrial and governmental customers. It is managed as one segment: a community bank. It generates revenue from net interest income.

Share on Social Networks: